BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/28/2016 3:54:00 PM | Browse: 1272 | Download: 2134
Publication Name World Journal of Hematology
Manuscript ID 22838
Country Australia
ISSN 2218-6204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Hematology
Manuscript Type Review
Article Title Insights into myelodysplastic syndromes from current preclinical models
Manuscript Source Invited Manuscript
All Author List Shuh Ying Tan, Monique F Smeets, Alistair M Chalk, Harshal Nandurkar, Carl R Walkley, Louise E Purton and Meaghan Wall
Funding Agency and Grant Number
Funding Agency Grant Number
The Leukemia Foundation
Victorian State Government Operational Infrastructure Support Scheme
NHMRC
Corresponding Author Meaghan Wall, MBBS, PhD, Victorian Cancer Cytogenetics Service, St. Vincent’s Hospital, 41 Victoria Parade, Fitzroy 3065, Victoria, Australia. meaghan.wall@svha.org.au
Key Words Myelodysplastic syndromes; Mouse models; Genetic mutations
Core Tip Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic disorders. In recent years, we have witnessed a rapidly expanding catalog of MDS candidate genes. Mirroring this, there has been an increased number of candidate genes employed to model MDS. Here, we aim to review currently avai-lable mouse models of MDS, highlighting models that are robust and well-characterized phenotypically with a particular focus on models that demonstrate close resemblance to the human disease.
Publish Date 2016-01-28 15:54
Citation Tan SY, Smeets MF, Chalk AM, Nandurkar H, Walkley CR, Purton LE, Wall M. Insights into myelodysplastic syndromes from current preclinical models. World J Hematol 2016; 5(1): 1-22
URL http://www.wjgnet.com/2218-6204/full/v5/i1/1.htm
DOI http://dx.doi.org/10.5315/wjh.v5.i1.1
Full Article (PDF) WJH-5-1.pdf
Full Article (Word) WJH-5-1.doc